Nariyoshi SHINOMIYA, M.D., Ph.D., was a professor and the president of the National Defense Medical College (NDMC) until 2024. Currently, he is Professor Emeritus at the NDMC and a visiting senior researcher at the National Institute of Infectious Diseases, Japan Institute for Health Security. His areas of expertise are microbiology/immunology and molecular oncology. His research interests include radiosensitivity and apoptosis of tumor cells, Met tyrosine kinase function and regulation of tumor growth, etc. He served as President of the Japan Human Cell Society from 2015 to 2023.
Yutaka SHIMADA, M.D., Ph.D., FACS, has been a professor at the Department of Nanobio Drug Discovery at Kyoto University. He established more than 60 human esophageal cancer cell lines (KYSE-series) and 10 pancreatic cancer cell lines (KMP-series, TYPK-series). He has also established several gallbladder and bile duct cancer cell lines. His recent research focuses on establishing a standard method for culturing circulating tumor cells. He served as Vice President of the Japan Human Cell Society from 2015 to 2023.